BioCentury
ARTICLE | Financial News

MedImmune off on downgrade

October 2, 2000 7:00 AM UTC

MEDI was down $20.50 (27 percent) to $56.75 on Monday after Banc of America analyst Eric Ende lowered his rating to "market performer" from "buy." Ende lowered his non-U.S. sales estimate for MEDI's S...